INTRODUCTION
Papillon-Lefèvre syndrome (PLS, OMIM: 245000) is a rare inherited autosomal recessive disorder characterized by palmoplantar hyperkeratosis and an early and severe periodontitis, causing loss of both the primary and permanent teeth. The prevalence of PLS is 1 to 4 cases per million people and the carrier rate is 2 to 4 per 1000. There is no gender predilection but parental consanguinity has been reported in more than 50% of cases 1, 2 .
Palmoplantar keratoderma may be visible at birth or 1 to 2 months thereafter, but generally, keratoderma and periodontitis develop in parallel between the 6th month and the 4th year of life of the patient, and often coincide with the eruption of the first teeth 3 . Other symptoms can also occur such as mental retardation, intracranial calcifications, recurrent skin infections, hyperhidrosis and liver abscesses 2, 4 . The disease-causing gene, cathepsin C (CatC) (CTSC) 5, 6 is located on chromosome 11q14-21 [7] [8] [9] . To date, 75 mutations have been reported for PLS patients, of which 68% were homozygous for one dysfunctional allele. Fifty percent of homozygous mutations were missense, 25% nonsense, 23% frameshift, and 2% were other types of mutations 10 . In addition to the classic form of PLS, 6 cases with late-onset periodontal disease and/or late-onset palmoplantar-lesions were reported 11 . Haim-Monk syndrome, allelic to PLS has been described in a Jewish community in India, with arachnodactyly, acroosteolysis and onychogryphosis as additional features 13 . The diagnosis of PLS is based on clinical signs and is generally confirmed by exon sequencing. This latter procedure, however, has several drawbacks, the relatively high costs in comparison to the low socio-economic status of the patients from countries with frequent intrafamilial marriages, the uncertain interpretation of rare benign mutations and/or the unavailability of an appropriate platform for DNA preparation and sequence analysis 14, 15 .
CatC, also known as dipeptidyl peptidase I (DPPI, EC 3.4.14.1) is a lysosomal cysteine exopeptidase belonging to the papain superfamily of cysteine peptidases 16 Demographics and clinical data from patients are summarized in Table I . After centrifugation (3000 g, 15 min) at 4°C to eliminate cells and debris, the urine supernatants were concentrated 20 or 120 times using Vivaspin 15R concentrators (molecular mass cutoff, 10 kDa; Sartorius, Goettingen, Germany) and store at 4°C.
MATERIALS AND METHODS

Reagents
Urine collection
Western blotting analysis
Briefly, urine samples were electrophoretically separated on a 10% SDS-PAGE in reducing conditions for CatC analysis and in non-reducing conditions for APN analysis, and then transferred to a nitrocellulose membrane (Amersham Biosciences, Uppsala, Sweden).
After saturation, membranes were incubated with anti-CatC Abs (Ab1 and Ab3 diluted 1:500; (IGEPAL 630), and after centrifugation (10000 g, 15 min at 4°C), the lysate was stored at -20°C. Cell supernatants were concentrated 30 times using Vivaspin 15R concentrators (molecular mass cutoff, 10 kDa; Sartorius). Proteins in lysates and in supernatants were quantified with a bicinchoninc acid assay (BCA) (Thermo Scientific, Rockford, IL, USA).
Genetic investigations
Patient's genomic DNA and when available parents DNA was extracted from EDTA blood samples with the automated method EVO ® 100 ReliaPrep (Tecan, Promega).
PCR and sequencing reaction: The in vitro amplification and sequencing of all CTSC exons and intron-exon boundaries were performed as described in 21 
RESULTS
Pro and mature CatC in urine of healthy subjects
We We did not observe any pro or mature CatC in plasma by immunoblotting (data not shown).
Plasma-derived CatC, moveover, would hardly be expected to cross the kidney filtration barrier because of its large tetrameric Mr of ~200 kDa. We found however that human bladder cells (T24/T24M) and canine kidney epithelial cells (MDCK) produced and secreted proCatC but not the mature protease (not shown). To learn whether proCatC is converted into active CatC in urine, we compared the ratio between proCatC and fully processed and active CatC in a urine sample before and after a 24h incubation time at 37°C. No change in this ratio was observed strongly suggesting that proCatC processing active proteinases do not occur in urine (data not shown).
CatC in urine of patients with a PLS phenotype
31 urine samples were collected from clinically diagnosed or suspected PLS patients from different European, American and Asian countries ( Table I) . Urine samples were centrifuged upon receipt, concentrated (x120) and analyzed for the presence and activity of CatC as described for control subjects ( Figure 3A) . A sequencing-based PLS diagnosis was previously established for 21 patients allowing the identification of either nonsense, frameshift 8 or missense mutations in the CTSC gene (Table I) . In spite of the greater concentration of PLS urine samples (x120 vs x20 in controls) no pro or active CatC was detected in any of these patients whatever the type of mutation was ( Table I) . We used the measurement of aminopeptidase N activity as a positive control to check the quality of the urine sample (data not shown). Of the 10 remaining patients whose PLS diagnosis was only based on clinical features (Table I) Urinary CatC activity was fully inhibited by the specific CatC inhibitor Thi-Phe-CN (data not shown). At least one of these polymorphisms came from his father but his mother presented a periondontitis and anomalies of deciduous teeth ( Figure 4C ). The urine of the mother also contained pro and mature CatC ( Figure 4D ). Mature CatC was present in a lysate of white blood cells from the son and his mother, and it compared with that of a healthy subject.
Further, proteolytically active elastase-like proteases were present in white blood cell lysates indicating that functional CatC was present in cells and tissues (data not shown).
DISCUSSION
Clinical signs of the classical PLS become apparent by the age of one to five years when dry, scaly patches appear on the skin of palms and soles, and severe inflammation starts to affect the surrounding gingiva and bone of primary teeth, leading to their rapid lost. The genetic etiology of PLS has been clearly established but it still remains unclear why a lack of CatC activity leads to specific dermatological lesions and severe destructive periodontitis on the long run. A plausible explanation for the development of chronic periodontitis is the deficiency of the antimicrobial peptide LL-37 in the gingiva, allowing for infection with A. PLS may be underdiagnosed and more prevalent than documented at present 27 .
CatC is expressed as a pro-proteinase by epithelial and myeloid cells and their precursors and is activated by a multistep mechanism possibly involving several proteinases 5, 17, 22 . Thus pro-and/or mature CatC may be constitutively present in a variety of cells and tissues including renal and/or bladder epithelial cells. Here we evaluated the hypothesis that urine from healthy and diseased persons is in fact a reliable source of pro-or active CatC that can be easily characterized and analyzed for by enzymatic and/or immunochemical methods.
In this study, we found that the absence of active CatC and its proform in the urine was a strong and reliable indicator for PLS and of great value for the early diagnosis of PLS. (10) --
